Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Burns

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of CYT997: a structurally novel orally active microtubule targeting agentChristopher J Burns, Michael F Harte, Xianyong Bu, et al.
Oncotarget|September 24, 2017
Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropeniaKate McArthur, Akshay A D'Cruz, David Segal, et al.
Plos One|January 24, 2015
HSP90 inhibition suppresses lipopolysaccharide-induced lung inflammation in vivoAndrew Lilja, Clare E Weeden, Kate McArthur, et al.
Structure (London, England : 1993)|August 23, 2016
Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1Onisha Patel, Weiwen Dai, Mareike Mentzel, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design?Christopher J Burns, Robert D Groneberg, Joseph M Salvino, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2009
Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMSChristopher J Burns, Michael F Harte, Xianyong Bu, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymeraseRandy W Jackson, Matthew G LaPorte, Torsten Herbertz, et al.
Burns : Journal of the International Society for Burn Injuries|April 6, 2024
A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot studyRoss I Donaldson, Jonathan K Armstrong, Oliver J Buchanan, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|August 22, 2014
Wound healing trajectories in burn patients and their impact on mortalityStephanie L Nitzschke, James K Aden, Maria L Serio-Melvin, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of CYT997: a structurally novel orally active microtubule targeting agentChristopher J Burns, Michael F Harte, Xianyong Bu, et al.
Oncotarget|September 24, 2017
Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropeniaKate McArthur, Akshay A D'Cruz, David Segal, et al.
Plos One|January 24, 2015
HSP90 inhibition suppresses lipopolysaccharide-induced lung inflammation in vivoAndrew Lilja, Clare E Weeden, Kate McArthur, et al.
Structure (London, England : 1993)|August 23, 2016
Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1Onisha Patel, Weiwen Dai, Mareike Mentzel, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design?Christopher J Burns, Robert D Groneberg, Joseph M Salvino, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2009
Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMSChristopher J Burns, Michael F Harte, Xianyong Bu, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymeraseRandy W Jackson, Matthew G LaPorte, Torsten Herbertz, et al.
Burns : Journal of the International Society for Burn Injuries|April 6, 2024
A novel, reverse-phase-shifting, thermoreversible foaming hydrogel containing antibiotics for the treatment of thermal burns in a swine model - A pilot studyRoss I Donaldson, Jonathan K Armstrong, Oliver J Buchanan, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|August 22, 2014
Wound healing trajectories in burn patients and their impact on mortalityStephanie L Nitzschke, James K Aden, Maria L Serio-Melvin, et al.
Pageof 7